Comments
Loading...
eFFECTOR Therapeutics Analyst Ratings and Price Targets | OTC:EFTRW | Benzinga
eFFECTOR Therapeutics Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for eFFECTOR Therapeutics Corp from these most-recent analyst ratings.
Analyst Ratings for eFFECTOR Therapeutics
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for eFFECTOR Therapeutics (EFTRW) stock?
There is no price target for eFFECTOR Therapeutics
What is the most recent analyst rating for eFFECTOR Therapeutics (EFTRW)?
There is no analyst for eFFECTOR Therapeutics
When was the last upgrade for eFFECTOR Therapeutics (EFTRW)?
There is no last upgrade for eFFECTOR Therapeutics
When was the last downgrade for eFFECTOR Therapeutics (EFTRW)?
There is no last downgrade for eFFECTOR Therapeutics.
When is the next analyst rating going to be posted or updated for eFFECTOR Therapeutics (EFTRW)?
There is no next analyst rating for eFFECTOR Therapeutics.
Is the Analyst Rating eFFECTOR Therapeutics (EFTRW) correct?
There is no next analyst rating for eFFECTOR Therapeutics.
Browse analyst ratings and price targets on all stocks.
